Characterization of Secondary Hyperalgesia in Healthy Volunteers
NCT ID: NCT02166164
Last Updated: 2015-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2014-06-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore we wish to investigate how precise the psychological tests, Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia
NCT02527395
The Effects of Pain and Pain Relief on Peripheral Nerve Excitability
NCT06356376
Experiences of Pain in Healthy Adults
NCT06611267
Experimental Pain in Parkinsons
NCT05981261
Influence of Expectations on Change in Pain Perception After a 3 Min Wallsquat Exercise.
NCT03678662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experiemental pain models
all study participants will be tested with the same experimental pain models: Brief thermal sensitization, Long thermal stimulation, and Heat-pain-detection threshold.
Brief thermal sensitization
A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.
Long thermal stimulation
A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute. During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.
Heat-pain-detection threshold
The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered.
4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief thermal sensitization
A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.
Long thermal stimulation
A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute. During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.
Heat-pain-detection threshold
The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered.
4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak and understand Danish
* Male gender
* Test subjects who have understood and signed the informed consent
* No prescription medicine during the last 30 days
Exclusion Criteria
* Test subjects with an alcohol and/or substance abuse, assessed by the investigator
* Test subjects, who have consumed one or several types of analgesics 2 \<days before the study
* Test subjects, who have consumed antidepressant medication during the last 30 days before the study
* Test subjects with chronic pain
* Test subjects with psychiatric diagnoses
* Test subjects with tattoos on the extremities
* Body Mass Index of \>30 or \<18
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Copenhagen Trial Unit, Center for Clinical Intervention Research
OTHER
University of Copenhagen
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Sejer Hansen
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jørgen B Dahl, MD, Doc. Med, Consultant
Role: STUDY_DIRECTOR
Department of anaesthesiology, dep. Z, Bispebjerg Hospital, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of anaesthesia and surgery, 4231, Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hansen MS, Wetterslev J, Pipper CB, Ostervig R, Asghar MS, Dahl JB. The Area of Secondary Hyperalgesia following Heat Stimulation in Healthy Male Volunteers: Inter- and Intra-Individual Variance and Reproducibility. PLoS One. 2016 May 11;11(5):e0155284. doi: 10.1371/journal.pone.0155284. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SM1-MSH-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.